Emerging Medical Treatments for Meningioma in the Molecular Era

Fares Nigim, Hiroaki Wakimoto, Ekkehard M. Kasper, Linda Ackermans, Yasin Temel

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Article number86
Number of pages21
JournalBiomedicines
Volume6
Issue number3
DOIs
Publication statusPublished - 1 Sep 2018

Keywords

  • World Health Organization (WHO)
  • Grade I
  • II
  • and III Meningiomas
  • High Grade Meningiomas (HGMs)
  • tumor heterogeneity
  • genetic subtypes
  • overall survival (OS)
  • progression free survival (PFS)
  • targeted therapy
  • clinical trials
  • oncolytic virus (OV)
  • TERT PROMOTER MUTATIONS
  • GROWTH-FACTOR RECEPTOR
  • FOCAL-ADHESION KINASE
  • TUMOR-SUPPRESSOR GENE
  • HERPES-SIMPLEX-VIRUS
  • SKULL BASE MENINGIOMAS
  • OF-THE-LITERATURE
  • PHASE-II TRIAL
  • INTEGRATIVE GENOMIC ANALYSIS
  • PLECKSTRIN HOMOLOGY DOMAIN
  • RECURRENT MENINGIOMAS
  • SONIC HEDGEHOG PATHWAY

Cite this